Literature DB >> 3810480

Central serous retinopathy: variants.

D E Mazzuca, W E Benson.   

Abstract

Idiopathic central serous chorioretinopathy (ICSC) is a localized detachment of the sensory retina in the macula which is commonly seen by the general ophthalmologist. However, ICSC with bullous retinal detachment is a rare disease characterized by extensive sensory retinal detachment of the posterior pole and elsewhere. Thus far it has been reported in only nine Caucasian patients in the American literature. Two case reports are presented, one typifying ICSC, the other typifying ICSC with bullous retinal detachment. Although both entities probably share the same pathophysiologic mechanism, they are distinct in terms of diagnostic features and treatment. While ICSC is usually self-limiting and frequently diagnosed by history alone, ICSC with bullous retinal detachment is frequently misdiagnosed and subsequently treated improperly.

Entities:  

Mesh:

Year:  1986        PMID: 3810480     DOI: 10.1016/0039-6257(86)90036-6

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  4 in total

1.  Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy.

Authors:  Ji Eun Kang; Hyun Jin Kim; Hee Don Boo; Ha Kyoung Kim; Jeong Hee Lee
Journal:  Korean J Ophthalmol       Date:  2006-06

Review 2.  Bullous variant of idiopathic central serous chorioretinopathy.

Authors:  D K Sahu; P Namperumalsamy; G F Hilton; N F de Sousa
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

3.  Central serous chorioretinopathy in African Americans.

Authors:  Uday R Desai; Amir A Alhalel; Thomas J Campen; Rhett M Schiffman; Paul A Edwards; Gordon R Jacobsen
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

4.  Choroidal thickness changes in non-treated acute and ranibizumab-treated chronic central serous chorioretinopathy.

Authors:  Erhan Yumusak; Nesrin Buyuktortop Gokcinar; Kemal Ornek
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.